As circulating miRNAs are informative biomarkers for cancer diagnosis and prognosis [34, 35], we measured circulating miR-145 and ANGPT2 levels in both breast cancer patients and healthy controls. This evidence concerns the gene ANGPT2 and breast carcinoma.